Latest period
$69.9M
YoY change
-44.9%
5Y CAGR
-29.9%
Peak year (FY2020)
$476M
Latest annual
$80.4M
Stock-Based Compensation history chart for Teladoc Health (TDOC) from 2016 to 2025
Latest: $80.4M
Stock-Based Compensation growth chart for Teladoc Health (TDOC) from 2016 to 2025
Latest: -44.9%
Stock-Based Compensation history table for Teladoc Health (TDOC) from 2013 to 2025
| FY2025 | $80.4M | -44.9% | -$65.5M | ||
| FY2024 | $146M | -27.6% | -$55.6M | ||
| FY2023 | $202M | -7.5% | -$16.3M | ||
| FY2022 | $218M | -28.0% | -$84.7M | ||
| FY2021 | $303M | -36.4% | -$173M | ||
| FY2020 | $476M | +612.9% | +$409M | ||
| FY2019 | $66.7M | +52.4% | +$22.9M | ||
| FY2018 | $43.8M | +43.0% | +$13.2M | ||
| FY2017 | $30.6M | +296.2% | +$22.9M | ||
| FY2016 | $7.72M | +151.2% | +$4.65M | ||
| FY2015 | $3.08M | +476.9% | +$2.54M | ||
| FY2014 | $533K | +78.9% | +$235K | ||
| FY2013 | $298K | — | — |
- FY2025$80.4M-44.9%
- FY2024$146M-27.6%
- FY2023$202M-7.5%
- FY2022$218M-28.0%
- FY2021$303M-36.4%
- FY2020$476M+612.9%
- FY2019$66.7M+52.4%
- FY2018$43.8M+43.0%
- FY2017$30.6M+296.2%
- FY2016$7.72M+151.2%
- FY2015$3.08M+476.9%
- FY2014$533K+78.9%
- FY2013$298K—
Stock-Based Compensation values are taken from Teladoc Health's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Stock-Based Compensation at Teladoc Health (TDOC)
Stock-Based Compensation for Teladoc Health (TDOC): headline value $69.9M · YoY -44.9%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Teladoc Health (TDOC) stock-based compensation totalled $80.4M – plunged 44.9% year-over-year.
Teladoc Health stock-based compensation compound annual growth for the 2020–2025 (5 years) window is -29.9%, with a net decline across the window.
$476M stands as the all-time-high annual stock-based compensation, posted in 2020, against a low of $298K during 2013.
Teladoc Health Stock-Based Compensation by Year
Teladoc Health Stock-Based Compensation 2025: $80.4M
Teladoc Health posted stock-based compensation of $80.4M in 2025, plunged 44.9% below 2024.
Teladoc Health Stock-Based Compensation 2024: $146M
In 2024, Teladoc Health reported stock-based compensation of $146M, declined 27.6% below 2023.
Teladoc Health Stock-Based Compensation 2023: $202M
Teladoc Health stock-based compensation in 2023 was $202M, declined 7.5% below 2022.
Teladoc Health Stock-Based Compensation 2022: $218M
2022's stock-based compensation for Teladoc Health came in at $218M, declined 28.0% below 2021.
Teladoc Health Stock-Based Compensation 2021: $303M
Teladoc Health stock-based compensation in 2021 was $303M.
See more financial history for Teladoc Health (TDOC).
Sector peers by Stock-Based Compensation
Healthcare peers of Teladoc Health (TDOC), ranked by their latest stock-based compensation
| $1.35B | |
| $971M | |
| $955M | |
| $626M | |
| $494M | |
| $310M | |
| $0.00 | |
| $0.00 |
- $1.35B
- $955M
- $626M
- $494M
- $0.00
- $0.00
Frequently asked questions
Teladoc Health (TDOC) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.